Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: CG Oncology Inc., 2 years.
CG Oncology Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 3, 2025 | CG Oncology Inc. | Open-market sale | −69,695 | $27.60 | $1,923,582 |
| Sep 3, 2025 | CG Oncology Inc. | Open-market sale | −30,105 | $28.24 | $850,165 |
| Sep 3, 2025 | CG Oncology Inc. | Open-market sale | −100 | $28.96 | $2,896 |
| Sep 3, 2025 | CG Oncology Inc. | Open-market sale | −100 | $28.99 | $2,899 |
| Dec 16, 2024 | CG Oncology Inc. | Open-market sale | −700,000 | $28.00 | $19,600,000 |
| Aug 29, 2024 | CG Oncology Inc. | Open-market sale | −424,210 | $35.36 | $15,000,066 |
| Aug 29, 2024 | CG Oncology Inc. | Open-market sale | −226,245 | $35.36 | $8,000,023 |
| Jan 29, 2024 | CG Oncology Inc. | Derivative conversion | +350,771 | — | — |
| Jan 29, 2024 | CG Oncology Inc. | Derivative conversion | +1,011,192 | — | — |
| Jan 29, 2024 | CG Oncology Inc. | Derivative conversion | +3,930,176 | — | — |
| Jan 29, 2024 | CG Oncology Inc. | Open-market purchase | +263,157 | $19.00 | $4,999,983 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.